Jim Simons's position in Viridian Therapeutics is currently worth $178 Thousand. That's 0.00% of their equity portfolio (2949th largest holding). The first Viridian Therapeutics trade was made in Q1 2021. Since then Jim Simons bought shares three more times and sold shares on four occasions. The investor's estimated purchase price is $384 Thousand, resulting in a loss of 54%.